Novartis
Novartis Starts 'Strategic Review' Of India Listed Business Amid Reports Of Sale Talks
Eris Lifesciences
Eris Lifesciences (ERIS IN)
Rating: BUY | CMP: Rs924 | TP:Rs1,100
Q3FY24 Result Update – In line EBITDA; entering into injectable and RoW markets
Techno Electric & Engineering Co
Techno Electric & Engineering Co. Q3 FY24 (Consolidated, YoY)
Garden Reach Shipbuilders & Engineers
Garden Reach Shipbuilders & Engineers Q3 FY24 (Consolidated, YoY)